EKF Diagnostics Holdings plc (AIM: EKF)

London flag London · Delayed Price · Currency is GBP · Price in GBX
27.00
+1.30 (5.06%)
Jan 17, 2025, 4:35 PM GMT+1
-15.89%
Market Cap 116.61M
Revenue (ttm) 50.95M
Net Income (ttm) 4.78M
Shares Out 453.73M
EPS (ttm) 0.01
PE Ratio 24.42
Forward PE 20.66
Dividend 0.01 (4.55%)
Ex-Dividend Date n/a
Volume 671,116
Average Volume 209,534
Open 26.90
Previous Close 25.70
Day's Range 26.00 - 27.00
52-Week Range 23.00 - 34.00
Beta 0.58
RSI 49.97
Earnings Date Mar 21, 2025

About EKF Diagnostics Holdings

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; Ultracrit, a hematocrit device; DiaSpect Hemoglobin T analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. The company also provides glucos... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1990
Employees 317
Stock Exchange London Stock Exchange AIM
Ticker Symbol EKF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.